Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 850568-25-1 | MDL No. : | MFCD06659876 |
Formula : | C12H11BN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LEAZDTWQWNXKJM-UHFFFAOYSA-N |
M.W : | 242.04 | Pubchem ID : | 44119539 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 3.0 |
Molar Refractivity : | 68.28 |
TPSA : | 82.45 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.12 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.92 |
Log Po/w (WLOGP) : | -0.18 |
Log Po/w (MLOGP) : | 0.19 |
Log Po/w (SILICOS-IT) : | -0.55 |
Consensus Log Po/w : | 0.08 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.15 |
Solubility : | 1.72 mg/ml ; 0.00709 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.24 |
Solubility : | 1.4 mg/ml ; 0.00579 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.44 |
Solubility : | 0.0879 mg/ml ; 0.000363 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.87 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | With hydrogenchloride; sodium periodate In tetrahydrofuran; water at 20℃; for 3.5h; | (Pyridin-2-yl-amino) phenyl boronic acid B-1 toN- (pyridin-2-yl) -4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzamide(2 g, 6.2 mmol) in a mixed solvent of THF: H20 (24 mL: 6 mL) was added NaIO4(3.27 g, 18.6 mmol),And stirred at room temperature for 30 minutes.2N HCl aqueous solution (1.65 mL) was added.It was stirred at room temperature for 3 hours.The mixture was diluted with ethyl acetate,Wash with brine.Separated and dried over anhydrous Na2SO4,Filter and concentrate.Purification by column chromatography using MeOH / DCM = 1: 10 gave 1.4 g of the compound (pyridin-2-ylcarbamoyl) phenylboronic acid,Yield: 93%. |
93% | Stage #1: N-(pyridin-2-yl)-4-(4,4,5, 5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide With sodium periodate In tetrahydrofuran; water at 20℃; for 0.5h; Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20℃; for 3h; | (Pyridin-2-ylcarbamoyl) phenylboronic acid II-1 N- (pyridin-2-yl) -4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl) benzamide(2g, 6.2mmol) in a mixed solvent of THF: H2O (24mL: 6mL) was added NaIO4 (3.27g,18.6 mmol) and stirred at room temperature for 30 minutes. 2N aqueous HCl (1.65 mL) was added. It was stirred at room temperature for 3 hours. The mixture was diluted with ethyl acetate and washed with brine. Separate and dry with anhydrous Na2SO4, filter and concentrate.Purification by column chromatography using MeOH / DCM = 1: 10 gave the product (pyridin-2-ylcarbamoyl) phenylboronic acid II-1 (1.4 g, 93%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63% | In methanol at 5 - 50℃; for 3h; | 7 Example 7: Synthesis of compound XlV-b To a round-bottom flask was added compound IV (17.2 g), pinacol (12.6 g) and methanol (70 mL). The mixture was stirred for 2 h at 40~50 °C. The reaction mixture was cooled to 5 °C and stirred for 1 h. After filtration and drying, compound XlV-b was obtained as white solid (14.5 g, 63% yield).XH NMR (400 MHz, DMSO) δ 10.82 (s, 1H), 8.40 - 8.38 (m, 1H), 8.23 - 8.20 (m, 1H), 8.06 - 8.02 (m, 2H), 7.87 - 7.77 (m, 3H), 7.18 - 7.14 (m, 1H), 1.31 (s, 12H). |
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.74
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.73
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.73
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.73
[ 1056636-11-3 ]
(4-((Cyanomethyl)carbamoyl)phenyl)boronic acid
Similarity: 0.72
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.74
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.73
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.73
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.73
[ 1056636-11-3 ]
(4-((Cyanomethyl)carbamoyl)phenyl)boronic acid
Similarity: 0.72
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.74
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.73
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.73
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.73
[ 1056636-11-3 ]
(4-((Cyanomethyl)carbamoyl)phenyl)boronic acid
Similarity: 0.72
[ 860173-33-7 ]
(4-(Cyclopropylcarbamoyl)phenyl)boronic acid
Similarity: 0.74
[ 832695-88-2 ]
(3-(Methylcarbamoyl)phenyl)boronic acid
Similarity: 0.73
[ 121177-82-0 ]
4-(N-Methylaminocarbonyl)phenylboronic acid
Similarity: 0.73
[ 850568-22-8 ]
(4-((2-(Dimethylamino)ethyl)carbamoyl)phenyl)boronic acid hydrochloride
Similarity: 0.73
[ 1056636-11-3 ]
(4-((Cyanomethyl)carbamoyl)phenyl)boronic acid
Similarity: 0.72
[ 1220220-21-2 ]
N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide
Similarity: 0.67
[ 1290541-46-6 ]
(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one
Similarity: 0.65
[ 342417-01-0 ]
6-(4-Methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide
Similarity: 0.62
[ 903513-62-2 ]
(2-Aminopyridin-4-yl)boronic acid
Similarity: 0.61
[ 6531-74-4 ]
N-Carbamimidoylisonicotinamide
Similarity: 0.61